ClinicalTrials.gg
Not yet recruitingNCT07944456Updated Nov 18, 2026

High-Intensity Interval Training, Inflammatory Biomarkers, and Circulating MicroRNAs in Human Clinical Obesity.

An interventional study of High-Intensity Interval Training (HIIT) in Obese Adults, sponsored by Universidad Nacional Andres Bello. Not yet recruiting at 1 site in Chile. Open to participants aged 20 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Universidad Nacional Andres Bello · Not applicable, Interventional, and Basic science

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Randomized
Ages
20 Years to 39 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 54 studies in Motor Activity with a site in Chile — 17 open to participants now, 20 under way, none of them phase 3. Motor Activity · Chile.

Planned enrollment
48th of 50
17 · median 60
Started
2026
with 5 others
No phase
49 of 54
15 open now
Primary completion
2027-06
later than 18 of 19 live
Registered
54th of 54
by date

Among the 54 studies in Motor Activity with a site in Chile, this one is the 48th largest by planned enrollment of the 50 interventional ones that give a count, is one of 6 that started in 2026, is one of 49 with no phase, reaches primary completion later than 18 of the 19 other live ones, and was the 54th registered.

Motor Activity

9,824 studies on the registry are indexed under Motor Activity; 1,917 are open to participants now.

Browse Motor Activity studies →

Open to participants now

17 of the 54 studies in Motor Activity with a site in Chile are open now. Recruiting first, the newest first:

11 more — sign in →

All 17 open studies →

A study can be open while its sites in Chile have not opened yet or have stopped. Only those recruiting at a site in Chile →

Who these studies take

Of the 1,210 Motor Activity studies recruiting now, 522 (43%) set no upper age limit and 540 (45%) stop at 75 or younger; 180 take children under 18; 422 take healthy volunteers.

This study: 20 Years to 39 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies in Motor Activity with a site in Chile, or all of them as a file.
02

Study summary

This randomized controlled trial evaluates the effects of high-intensity interval training (HIIT) on body composition, inflammatory biomarkers, and circulating microRNAs in adults with clinical obesity. Circulating microRNAs are small regulatory molecules that may reflect exercise-induced adaptations and inter-tissue communication related to skeletal muscle and metabolic health. The study investigates whether exercise-induced changes in adiposity are accompanied by changes in inflammatory status and circulating microRNA profiles associated with skeletal muscle adaptations and metabolic health.

Read the detailed description

Clinical obesity is characterized by excessive adiposity accompanied by impaired metabolic health and chronic low-grade inflammation. Emerging evidence suggests that obesity is also associated with alterations in circulating molecular biomarkers that may influence skeletal muscle function and inter-tissue communication.

High-intensity interval training (HIIT) is an effective exercise strategy for improving body composition and cardiometabolic health; however, the molecular mechanisms underlying these adaptations remain incompletely understood. In particular, limited information is available regarding the response of circulating muscle-related microRNAs (myomiRs) to exercise interventions in adults with clinical obesity.

This randomized controlled trial is designed to investigate physiological and molecular adaptations to HIIT in adults with clinical obesity. The study will examine the relationship between changes in adiposity, systemic inflammation, and circulating microRNA expression following a supervised exercise intervention. Circulating microRNAs may provide insight into exercise-responsive biological pathways and represent potential biomarkers of skeletal muscle adaptation and metabolic health.

The findings may improve understanding of the molecular mechanisms associated with exercise-induced health benefits in clinical obesity and contribute to the identification of novel biomarkers relevant to obesity management and precision exercise medicine.

03

Conditions studied

  • Obese Adults

Browse trials for

Keywords

  • High-Intensity Interval Training
  • Clinical Obesity
  • Myo-miRs
  • Exercise
04

Who can participate

Ages eligible
20 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 20 to 39 years.
  • Clinical obesity defined primarily by body fat percentage (>29% in women and >20% in men), complemented by (BMI ≥30 kg/m²) and waist-to-height ratio (≥0.55).
  • Low habitual physical activity level, defined as not meeting the criteria for moderate or high physical activity according to the International Physical Activity Questionnaire-Short Form (IPAQ-SF).

Exclusion criteria

Exclusion Criteria:

  • Cardiovascular disease.
  • Metabolic disease (e.g., type 2 diabetes mellitus or dyslipidemia).
  • Inflammatory or disease (e.g., rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, or psoriasis).
  • Current smoking.
  • Chronic medication use that may affect metabolic or inflammatory outcomes.
  • Pregnancy and lactation.
  • Participation in a structured exercise program within the previous 6 months. to high-intensity exercise.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
17 participants (estimated)

Study arms

  • Experimental
    High-Intensity Interval Training (HIIT)

    Participants assigned to this arm will complete a supervised high-intensity interval training (HIIT) program performed on a cycle ergometer three times per week during 8 weeks. Each training session will last approximately 30 minutes and include a warm-up, high-intensity intervals performed at approximately 90% of maximal power output, active recovery periods, and a cool-down. All sessions will be supervised by qualified personnel to ensure participant safety and adherence to the protocol.

    Behavioral: High-Intensity Interval Training (HIIT)

  • No intervention
    Control

    Participants assigned to this arm will maintain their habitual lifestyle without participating in a structured exercise program during the intervention period. Educational materials on healthy lifestyle habits will be provided at the end of the study.

Interventions

  • BehavioralHigh-Intensity Interval Training (HIIT)

    Participants will complete a supervised high-intensity interval training (HIIT) program performed on a cycle ergometer three times per week during eight weeks. Each session will last approximately 30 minutes and consist of a warm-up, ten 1-minute high-intensity intervals performed at approximately 90% of maximal power output, interspersed with 1-minute active recovery periods, and a cool-down. Training intensity will be reassessed midway through the intervention to ensure appropriate progression. All sessions will be supervised by qualified personnel to promote adherence, proper exercise execution, and participant safety.

06

What researchers measure

Primary outcomes

  1. Total Body Fat Mass Assessed by Bioelectrical Impedance Analysis

    Total body fat mass (kg) will be assessed using bioelectrical impedance analysis and compared between baseline and post-intervention measurements.

    Time frame: Change from baseline to Week 8

Secondary outcomes

  1. Plasma Interleukin-1β (IL-1β) and Tumor Necrosis Factor-α (TNF-α) concentration Assessed by ELISA

    Plasma IL-1β concentration (pg/mL) and TNF-α concentration (pg/mL) measured by enzyme-linked immunosorbent assay (ELISA).

    Time frame: From baseline to Week 8

  2. Circulating Myo-MicroRNAs

    Change in circulating expression of miR-1, miR-133, and miR-206 quantified by RT-qPCR.

    Time frame: from enrollment to the end of treatment at 8 weeks

  3. Peak Oxygen Uptake (VO₂peak)

    Change in cardiorespiratory fitness assessed by peak oxygen uptake during an incremental cycling test.

    Time frame: From baseline to Week 8

  4. Handgrip Strength

    Change in maximal handgrip strength assessed using a hydraulic hand dynamometer.

    Time frame: From baseline to Week 8

  5. Maximal Voluntary Isometric Contraction (MVC)

    Change in maximal isometric strength of the knee extensor muscles measured by dynamometry.

    Time frame: From baseline to Week 8

  6. Health-Related Quality of Life Assessed Using the 36-Item Short Form Health Survey (SF-36)

    Change in health-related quality of life assessed using the 36-Item Short Form Health Survey (SF-36). Scores range from 0 to 100, with higher scores indicating better perceived health status and quality of life.

    Time frame: From baseline to Week 8

07

Study locations

1 site
  • Exercise and Rehabilitation Sciences Institute, School of Physical Therapy, Faculty of Rehabilitation Sciences, Universidad Andres Bello.
    Santiago, Metropolitan Region, Chile
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.

Of 5,170 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 7 months is below that.

Counting every sponsor, half of 5,230 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 29, 2026
First posted
Nov 18, 2026
StartEst.
Nov 2026
Primary completionEst.
Jun 2027
CompletionEst.
Oct 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07944456
Lead sponsor
Universidad Nacional Andres Bello
Responsible party
Sofia Uribe-Cerda (Principal Investigator, Universidad Nacional Andres Bello) — Principal investigator
First posted
Nov 18, 2026
Start date
Nov 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Sofia Uribe-Cerda, MSc.
Contact
s.uribecerda@uandresbello.edu
+56 975396081
Mayalen Valero Breton, PhD.
Contact
mayalen.valero@unab.cl
+56 992204392

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion